StephenRandolphZukinMD

PubMed

• 1 citation
  A Novel Once-Daily Fixed-Dose Combination of Memantine Extended Release and Donepezil for the Treatment of Moderate to Severe Alzheimer’s Disease: Two Phase I Studies ...
  Ramesh Boinpally, Laishun Chen, S. Zukin, Natalie McClure, Robert K. Hofbauer, Antonia Periclou> ;Clinical Drug Investigation. 2015 May 28
• AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
  Robert E. Litman, Mark A. Smith, James J. Doherty, Alan J. Cross, Shane Raines, Lev Gertsik, Stephen R. Zukin> ;Schizophrenia Research. 2014 Apr 1
• A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries
  Steven M. Silverstein, Judith Jaeger, Anne Marie Donovan-Lepore, Sandra Wilkniss, Adam Savitz, Igor Malinovsky, Danielle Hawthorne, Shane Raines, Sarah J. Carson, Step...> ;Journal of Clinical and Experimental Neuropsychology. 2010 May 7
• Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving.
  Dean Wong, Hiroto Kuwabara, David J. Schretlen, Katherine R. Bonson, Yun Zhou, Ayon Nandi, James R. Brasic, Alane S. Kimes, Marika Maris, Anil Kumar, Carlo Contoreggi,...> ;Neuropsychopharmacology. 2006 Dec 1
• Adjunctive high-dose glycine in the treatment of schizophrenia.
  Daniel C. Javitt, Gail Silipo, Angel Cienfuegos, Anne Marie Shelley, Nigel Bark, Mohan Park, Jean Pierre Lindenmayer, Ray Suckow, Stephen R. Zukin> ;The International Journal of Neuropsychopharmacology. 2001 Dec 1
• Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence re...
  Sparenborg, S., Vocci, F., Zukin, S.> ;Drug Alcohol Depend. 1997 Dec 15
• Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial
  Eduardo A. Leiderman, Ilana Zylberman, Stephen R. Zukin, Thomas B. Cooper, Daniel C. Javitt> ;Biological Psychiatry. 1996 Feb 1
• Pharmacological Augmentation of NMDA Receptor Function for Treatment of Schizophreniaa
  Ilana Zylberman, Daniel C. Javitt, Stephen R. Zukin> ;Annals of the New York Academy of Sciences. 1995 May 1
• Amelioration of negative symptoms in Schizophrenia by glycine
  Daniel C. Javitt, Ilana Zylberman, Stephen R. Zukin, Uriel Heresco-Levy, Jean-Pierre Lindenmayer> ;American Journal of Psychiatry. 1994 Aug 1
• Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex.
  Daniel C. Javitt, M J Frusciante, Stephen R. Zukin> ;Journal of Pharmacology and Experimental Therapeutics. 1994 Aug 1
• Phencyclidine receptor binding as a probe of NMDA receptor functioning: implications for drug abuse research.
  Stephen R. Zukin, D. C. Javitt> ;NIDA research monograph. 1993 Jan 1
• High efficiency reconstitution of a phencyclidine/MK-801 receptor binding site solubilized from rat forebrain membranes.
  R Haring, D E Pellegrini-Giampietro, Stephen R. Zukin, R S Zukin, M A Scheideler> ;Molecular Pharmacology. 1991 Nov 1
• Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
  Ilana Zylberman Nussenzveig, Ratna Sircar, Ma-Li Wong, Mark J. Frusciante, Daniel C. Javitt, Stephen R. Zukin> ;Brain Research. 1991 Oct 11
• Recent advances in the phencyclidine model of schizophrenia.
  Daniel C. Javitt, Stephen R. Zukin> ;American Journal of Psychiatry. 1991 Oct 1
• Kinetic mechanisms of glycine requirement for N-methyl-D-aspartate channel activation.
  Ratna Sircar, Stephen R. Zukin> ;Brain Research. 1991 Aug 16
• Modulation of phencyclidine receptors by excitatory amino acid receptor ligands.
  Javitt, D. C., Zukin, S. R.> ;Psychopharmacol Bull. 1988
• Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
  Daniel C. Javitt, Mark J. Frusciante, Stephen R. Zukin> ;Molecular Pharmacology. 1990 May 1
• Photoaffinity labeling and binding studies reveal the existence of two types of phencyclidine receptors in the NCB-20 cell line
  Rachel Haring, R. Suzanne Zukin, Stephen R. Zukin> ;Neuroscience Letters. 1990 Apr 20
• The role of excitatory amino acids in neuropsychiatric illness.
  D. C. Javitt, Stephen R. Zukin> ;Journal of Neuropsychiatry and Clinical Neurosciences. 1990 Jan 1
• Glycine reverses 7-chlorokynurenic acid-induced inhibition of [3H]MK-801 binding
  Ratna Sircar, Mark J. Frusciante, Daniel C. Javiet, Stephen R. Zukin> ;Brain Research. 1989 Dec 18
• High-dose naloxone in tardive dyskinesia.
  Lindenmayer, J. P., Gardner, E., Goldberg, E., Opler, L. A., Kay, S. R., van Praag, H. M., Weiner, M., Zukin, S.> ;Psychiatry Res. 1988 Oct
• Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels.
  Daniel C. Javitt, Stephen R. Zukin> ;Molecular Pharmacology. 1989 Apr 1
• Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research.
  Stephen R. Zukin, D. C. Javitt> ;NIDA research monograph. 1989 Jan 1
• Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain.
  Daniel C. Javitt, Stephen R. Zukin> ;Proceedings of the National Academy of Sciences of the United States of America. 1989 Jan 1
• Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
  L Kushner, Stephen R. Zukin, R S Zukin> ;Molecular Pharmacology. 1988 Nov 1
• Join now to see all